Related Experiment Video
Updated: Aug 8, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Severe disseminated tuberculosis in a 4-month-old infant initially presenting with multiform cutaneous lesions
Nikos Spyridis1, Heleni Georgouli, Theano Tsoukatou
1Department of General Paediatrics, St Thomas' Hospital, London, UK. niksp@netbreeze.co.uk
Insights
Disseminated tuberculosis in an infant caused horizontal nystagmus and skin lesions. Early diagnosis and treatment with anti-tuberculosis drugs resolved skin issues but neurological deficits remained.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Disseminated tuberculosis (TB) is rare in infants.
- Tuberculosis can present with varied dermatological manifestations.
- Neurological involvement in infant TB requires prompt recognition.
Observation:
- A 4-month-old infant presented with horizontal nystagmus and multiform skin lesions.
- Initial diagnosis of congenital nystagmus and staphylococcal infection was unresponsive to treatment.
- Development of severe systemic symptoms prompted further investigation.
Findings:
- Extensive investigations confirmed disseminated tuberculosis caused by Mycobacterium tuberculosis (MTB).
- MTB was isolated from both skin lesions and cerebrospinal fluid.
- Treatment included isoniazid, rifampicin, pyrazinamide, streptomycin, and dexamethasone.
Implications:
- Early diagnosis of disseminated TB in infants is crucial.
- Prompt anti-tuberculosis treatment can resolve cutaneous manifestations.
- Severe neurological deficits may persist despite treatment, highlighting the impact of TB on infant neurodevelopment.
Abstract:
A 4-month-old female infant presented with 1 month history of horizontal nystagmus and discrete multiform skin lesions. The patient was initially diagnosed with congenital nystagmus and staphylococcal skin infection not responding to antimicrobial agents. The development of severe systemic symptoms led to extensive investigations and the diagnosis of disseminated tuberculosis. Mycobacterium tuberculosis (MTB) was isolated from the skin and cerebrospinal fluid. The patient was treated with isoniazid, rifampicin, pyrizinamide, streptomycin and dexamethasone. Skin lesions resolved completely but severe neurological deficits persisted.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis